Last Updated on October 9, 2024 by The Health Master
USFDA approval
Zydus Lifesciences, a prominent player in the pharmaceutical industry, has achieved a significant milestone with the final USFDA approval from the stringent US Food and Drug Administration (USFDA) to market its generic version of Valsartan tablets.
This green light covers a range of dosages, including 40mg, 80mg, 160mg, and 320mg.
Expanding Treatment Options for Hypertension and Heart Conditions
Valsartan, a well-established drug, is primarily prescribed for managing high blood pressure or hypertension.
Its therapeutic benefits extend to adults and even children as young as one year.
Moreover, this medication plays a crucial role in treating heart failure and enhancing survival rates post-heart attack.
Manufacturing and Market Potential
The production of these Valsartan tablets will be undertaken at Zydus Lifesciences‘ advanced formulation manufacturing facility strategically located in Ahmedabad SEZ – II, India.
Considering the substantial market demand, the original Valsartan brand (Diovan) generated impressive annual sales of $149.5 million in the United States alone (data as of May 2024).
A Testament to Zydus Lifesciences’ R&D Prowess
This latest USFDA approval underscores Zydus Lifesciences’ commitment to research and development.
With a robust portfolio of 400 USFDA approvals and over 460 ANDA filings since 2003, the company has solidified its position as a global pharmaceutical leader.
Disclaimer: This article is intended for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before starting any new medication.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA approval granted for Fluphenazine Hydrochloride Tablets USP
USFDA approval granted for Topiramate Capsules USP
USFDA approval granted for the drug used for Colon Cleansing
USFDA approval granted for the drug for the treatment of Migraine
USFDA approval granted for this chronic heart failure treatment drug
USFDA approval granted for generic Bromfenac Ophthalmic Solution
IPC waves off TABST in Indian Pharmacopoeia
USFDA issues Form 483 with 2 observations to Gland Pharma
USFDA approval granted for Fluphenazine Hydrochloride Tablets USP
War on Drugs: Anti-Narcotics Task Force on the Way
Schedule M: Over 100 Pharma MSMEs in Telangana on the Brink of Closure
CDSCO Panel approval granted for Clinical Trial On Linaclotide Capsules
Budget 2024: Mixed Bag for Indian Pharma Industry
Drug alert: 61 drug samples declared as NSQ in June 2024
Fire breaks out at Pharma Plant in Maharashtra
Drug recall: Sanofi recalls Allegra, Combiflam suspensions due to this reason
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
